(Q33419708)

26 July 2017

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer (English)

1 reference

triple-negative breast cancer

26 July 2017

1 reference

14

Steven A Narod

1 reference

26 July 2017

2

Robert T Pilarski

1 reference

26 July 2017

S R Young

1

1 reference

26 July 2017

Talia Donenberg

3

1 reference

26 July 2017

Charles Shapiro

4

1 reference

26 July 2017

Lyn S Hammond

5

1 reference

26 July 2017

Judith Miller

6

1 reference

26 July 2017

Karen A Brooks

7

1 reference

26 July 2017

Stephanie Cohen

8

1 reference

26 July 2017

Beverly Tenenholz

9

1 reference

26 July 2017

Damini Desai

10

1 reference

26 July 2017

Inuk Zandvakili

11

1 reference

26 July 2017

Robert Royer

12

1 reference

26 July 2017

Song Li

13

1 reference

26 July 2017

language of work or name

English

0 references

publication date

19 March 2009

1 reference

26 July 2017

1 reference

26 July 2017

9

1 reference

26 July 2017

86

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-9-86

26 July 2017

0 references

cites work

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

The BOADICEA model of genetic susceptibility to breast and ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

BRCA1 and BRCA2: 1994 and beyond

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2666759

The Exon 13 Duplication in the BRCA1 Gene Is a Founder Mutation Present in Geographically Diverse Populations

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-86

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-86

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-86

A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-86

Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer

21 January 2018

1 reference

12 December 2020

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO

1 reference

12 December 2020

Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

12 December 2020

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

1 reference

12 December 2020

Mutation screening using fluorescence multiplex denaturing gradient gel electrophoresis (FMD): detecting mutations in the BRCA1 gene

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-9-86

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference